Name: Latest research reports of Laurus Labs Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Laurus Labs Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

1018.4000 -11.00 (-1.07%)

NSE Dec 02, 2025 10:40 AM

New 52W High in past week

Volume: 493.1K

Laurus Labs Ltd.

30 Apr 2020

1018.40

-1.07%

Laurus Labs (BUY): Good beat; firm FY21 outlook target raised to Rs 630

Buy: Laurus Labs Ltd.

Target

BOB Capital Markets Ltd.

Laurus Labs reported a strong operational beat of 8%/20%/41% on sales/EBITDA/ PBT in Q4.

Laurus Labs Ltd. is trading above all available SMAs